HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $30 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on Cabaletta Bio (NASDAQ:CABA) and maintained a $30 price target.

June 14, 2024 | 3:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on Cabaletta Bio and maintained a $30 price target, indicating confidence in the company's future performance.
The reiteration of a Buy rating and the maintenance of a $30 price target by a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100